ADJUVANT DRUG THERAPY
Clinical trials for ADJUVANT DRUG THERAPY explained in plain language.
Never miss a new study
Get alerted when new ADJUVANT DRUG THERAPY trials appear
Sign up with your email to follow new studies for ADJUVANT DRUG THERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug duo aims to stop aggressive breast cancer's return
Disease control Not yet recruitingThis study tests whether a new drug, sacituzumab tirumotecan (Sac-TMT), followed by standard chemotherapy (capecitabine), works better than capecitabine alone to keep early-stage, high-risk triple-negative breast cancer from returning. About 420 women without BRCA gene mutations …
Matched conditions: ADJUVANT DRUG THERAPY
Phase: PHASE3 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Could tailored tamoxifen doses keep more breast cancer patients on treatment?
Disease control Not yet recruitingThis phase 3 trial tests whether adjusting tamoxifen doses based on individual metabolism can reduce the number of breast cancer patients who stop treatment early due to side effects. About 1,100 premenopausal or perimenopausal women with hormone-sensitive breast cancer will rece…
Matched conditions: ADJUVANT DRUG THERAPY
Phase: PHASE3 • Sponsor: Karolinska Institutet • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC